Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
Colorcon
McKinsey
Merck

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Calcineurin Inhibitor Immunosuppressant Drug Class List

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drugs in Drug Class: Calcineurin Inhibitor Immunosuppressant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz TACROLIMUS tacrolimus CAPSULE;ORAL 065461-003 Aug 10, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
Strides Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 090687-002 Jul 22, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms Inc TACROLIMUS tacrolimus OINTMENT;TOPICAL 200744-001 Sep 9, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd TACROLIMUS tacrolimus CAPSULE;ORAL 090509-001 May 12, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Strides Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 090687-003 Jul 22, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms Inc TACROLIMUS tacrolimus OINTMENT;TOPICAL 200744-002 Sep 9, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Belcher Pharms Llc TACROLIMUS tacrolimus CAPSULE;ORAL 206651-001 Nov 30, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
AstraZeneca
Medtronic
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.